APR 14, 202655 MINS READ
Carboxymethyl chitosan is synthesized by introducing carboxymethyl groups (-CH₂COOH) onto the chitosan molecule, which contains three reactive sites: the primary hydroxyl group at C6, the secondary hydroxyl group at C3, and the amino group at C2 16. The electronegativity difference between oxygen and nitrogen results in preferential nucleophilic substitution at hydroxyl sites, with the primary alcohol (C6) exhibiting higher reactivity than the secondary alcohol (C3) 16. Consequently, the predominant products are O-carboxymethyl chitosan (substitution at C6), N-carboxymethyl chitosan (substitution at amino groups), or N,O-carboxymethyl chitosan (mixed substitution) 1316.
The degree of substitution (DS) quantifies the average number of carboxymethyl groups per glucosamine unit and typically ranges from 0.2 to 1.8 818. A DS of 0.95 (95% substitution) has been reported for commercial-grade CMC 16, while highly substituted variants achieve DS values of 1.0–1.8 with viscosity-average molecular weights of 7.9×10⁵ to 9.0×10⁵ g/mol and deacetylation degrees of 85–95% 18. The substitution pattern profoundly influences solubility: CMC with >50% amino group substitution (fully carboxymethylated) is typically insoluble at pH ≤5, whereas CMC with 20–50% amino substitution (e.g., 25–35%) remains acid-soluble at pH 2–5, enabling formulation in acidic media such as lactic acid solutions 7.
Key structural parameters include:
The chemical reaction for O-carboxymethylation can be represented as:
Chitosan-OH + ClCH₂COONa (NaOH, isopropanol) → Chitosan-O-CH₂COONa + NaCl
For N-carboxymethylation:
Chitosan-NH₂ + ClCH₂COOH (alkaline conditions) → Chitosan-NH-CH₂COOH
The most widely adopted synthesis route involves alkalinization of chitosan followed by reaction with monochloroacetic acid or its sodium salt in alcoholic media 815. A representative protocol comprises:
This method enables precise control of DS by varying the molar ratio of monochloroacetate to chitosan, thereby tailoring CMC for specific applications (e.g., wound healing, moisturizing, hemostasis) 8.
To achieve selective C6 substitution while preserving amino groups, a three-step protection-substitution-deprotection strategy has been developed 15:
This O-CMC exhibits superior procoagulant activity, biodegradability, and antibacterial properties compared to N,O-CMC or N-CMC, and demonstrates enhanced adsorption of anionic species, proteins, and heavy metal ions 15.
An integrated deacetylation-carboxymethylation process directly converts chitin to high-DS, high-MW CMC 18:
This streamlined approach yields CMC with DS 1.0–1.8, MW 7.9×10⁵–9.0×10⁵ g/mol, and DD 85–95%, offering improved mechanical properties for film and hydrogel applications 18.
Quaternized carboxymethyl chitosan (QCMC) is synthesized by reacting N-substituted CMC with iodomethane in N-methyl-2-pyrrolidone (NMP) at pH 9 (adjusted with 1 M NaOH) for 12 hours, followed by anion exchange to obtain chloride or bromide salts 5. The degree of quaternization ranges from 20.3% to 41.5% 5. QCMC exhibits enhanced antimicrobial activity and mucoadhesive properties, making it suitable for ophthalmic and oral drug delivery 514.
Native chitosan is soluble only in dilute acidic solutions (pH <6) due to protonation of amino groups, limiting its utility in neutral or alkaline environments. Carboxymethylation introduces anionic carboxyl groups, conferring water solubility across a broad pH range 716. However, solubility is DS-dependent:
This tunable solubility enables formulation flexibility; for instance, acid-soluble CMC can be combined with chitosan in lactic acid solutions to create homogeneous antimicrobial films with enhanced bioactivity and reduced rigidity 7.
CMC solutions exhibit pseudoplastic (shear-thinning) behavior, with viscosity decreasing under applied shear. A 1% aqueous solution at 20°C typically displays viscosity of 23.0 mPa·s 16. Viscosity increases with molecular weight and concentration, and decreases with temperature. For ophthalmic applications, viscoelastic CMC solutions (0.5–2.0% w/v) provide lubrication and tissue protection during intraocular surgery 14.
Films and hydrogels derived from high-MW CMC (7.9×10⁵–9.0×10⁵ g/mol, DS 1.0–1.8) exhibit tensile strengths of 30–50 MPa and elongation at break of 15–25%, with elastic moduli in the range of 0.8–1.5 GPa 18. These mechanical properties are superior to those of low-MW or low-DS CMC, making high-performance CMC suitable for load-bearing tissue engineering scaffolds and durable wound dressings 18.
Thermogravimetric analysis (TGA) reveals that CMC undergoes initial weight loss at 80–120°C (moisture evaporation), followed by major decomposition at 220–280°C (decarboxylation and polymer backbone degradation) 3. The onset decomposition temperature increases with DS and MW, indicating enhanced thermal stability. Itaconylated CMC cross-linked gels exhibit improved thermal resistance, with decomposition onset shifted to 250–300°C 3.
CMC is stable in neutral aqueous solutions for extended periods (>12 months at 4°C) but undergoes gradual hydrolytic degradation in acidic (pH <4) or strongly alkaline (pH >10) environments 15. Enzymatic degradation by lysozyme and chitosanase proceeds more slowly than for native chitosan due to steric hindrance from carboxymethyl groups, with half-lives of 4–8 weeks in vitro 15. This controlled biodegradability is advantageous for sustained drug release and tissue engineering applications 36.
Itaconylated CMC hydrogels represent an advanced class of biomaterials with tunable mechanical properties and dual cross-linking networks 3. The synthesis involves:
The resulting hydrogels exhibit:
These hydrogels support cell proliferation and adhesion, making them suitable for tissue engineering, wound healing, and hemostatic applications 3. The compact, stable interpenetrating network facilitates nutrient and waste exchange while providing mechanical integrity 3.
Hyperosmolar CMC solutions (osmolarity: 350–450 mOsm/L) are effective in treating corneal edema by drawing excess fluid from the corneal stroma via osmotic pressure 1. These formulations also suppress bacterial growth on the ocular surface, reducing infection risk 1. Viscoelastic N,O-CMC solutions (1.0–2.0% w/v) serve as surgical adjuncts in cataract extraction and intraocular lens implantation, protecting corneal endothelium and maintaining anterior chamber depth 14.
CMC-based hemostatic sponges combine CMC with methyl cellulose, hydroxyethyl cellulose, and calcium alginate to achieve rapid blood clotting 10. The sponge formulation absorbs blood, swells to fill the wound cavity, and activates the coagulation cascade via platelet aggregation and fibrin network formation 10. Typical composition:
These sponges achieve hemostasis within 2–5 minutes in animal models of liver laceration and femoral artery injury 10. O-CMC-based dressings accelerate wound healing by promoting fibroblast migration, collagen deposition, and re-epithelialization, while preventing tissue adhesion and scar formation 15.
Hydroxypropyl chitosan/CMC polyelectrolyte complexes (PECs) encapsulate hydrophobic drugs (e.g., plant extracts) via electrostatic interaction between cationic hydroxypropyl chitosan and anionic CMC 6. These micron-sized spherical particles (mean diameter: 2–10 μm) exhibit:
These PECs are applied as agricultural biopesticide formulations, providing controlled release and environmental compatibility 6.
CMC serves as a matrix for in situ synthesis of ZnO nanoparticles, which are then applied to polyester/pineapple fiber blended fabrics 11. The ZnO/CMC bio-nanocomposite treatment imparts:
| Org | Application Scenarios | Product/Project | Technical Outcomes |
|---|---|---|---|
| Omnivision GmbH | Treatment of corneal edema and prevention of ocular infections in ophthalmology clinics and surgical settings. | Hyperosmolar Ophthalmic Solution | Hyperosmolar carboxymethyl chitosan composition (350-450 mOsm/L) effectively treats corneal edema by osmotic dehydration and suppresses bacterial growth on ocular surface. |
| IMEIK TECHNOLOGY DEVELOPMENT CO. LTD. | Tissue engineering scaffolds, aesthetic medicine fillers, hemostatic applications in surgery, and wound healing dressings. | Itaconylated CMC Hydrogel | Dual cross-linked network (5-40% pre-crosslinking plus irradiation) with elastic modulus 10-80 kPa, supports cell proliferation and provides controlled degradation (20-40% over 4 weeks). |
| Gyrus ACMI Inc. (Olympus Surgical Technologies America) | Surgical hemostasis for liver lacerations, vascular injuries, and intraoperative bleeding control in general and trauma surgery. | Hemostatic Sponge Formulation | Composite sponge containing 30-50% carboxymethyl chitosan achieves rapid hemostasis (2-5 minutes) through blood absorption, swelling, and coagulation cascade activation. |
| South China University of Technology | Agricultural biopesticide formulations for controlled release of plant extracts, providing antimicrobial synergy and environmental compatibility in crop protection. | Hydroxypropyl Chitosan/CMC Drug-Loaded Particles | Polyelectrolyte complex particles (2-10 μm) with 60-85% encapsulation efficiency provide sustained release (40-60% over 72 hours) and complete biodegradation in 4-6 weeks. |
| PHILIPPINE TEXTILE RESEARCH INSTITUTE (PTRI) | Antimicrobial and UV-protective functional textiles for polyester/pineapple fiber blended fabrics in apparel and medical textile applications. | ZnO/CMC Bio-Nanocomposite Textile Treatment | In-situ synthesized ZnO nanoparticles in carboxymethyl chitosan matrix improve UV protection factor by 10-15% and provide bactericidal activity against Klebsiella pneumoniae and Staphylococcus aureus. |